# PORTLAND VA MEDICAL CENTER: Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer with PTEN Loss

**Lab Budget Score:** 30/100

| Field | Value |
|---|---|
| Organization | PORTLAND VA MEDICAL CENTER |
| Location | PORTLAND, OR |
| Project | Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer with PTEN Loss |
| Project number | 5I01CX002517-03 |
| Mechanism | I01 |
| Institute | Veterans Affairs |
| Awarded | 2026-10-30 |
| Project period | 2024-01-01 to 2028-12-31 |
| UEI | E8GJCMVHFJ63 |

## Why this score
- Awarded in the last 30 days.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11291871). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.